hydroxypropyl-gamma-cyclodextrin has been researched along with buserelin in 1 studies
| Studies (hydroxypropyl-gamma-cyclodextrin) | Trials (hydroxypropyl-gamma-cyclodextrin) | Recent Studies (post-2010) (hydroxypropyl-gamma-cyclodextrin) | Studies (buserelin) | Trials (buserelin) | Recent Studies (post-2010) (buserelin) |
|---|---|---|---|---|---|
| 86 | 0 | 34 | 2,147 | 432 | 161 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Irie, T; Uekama, K | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and buserelin
| Article | Year |
|---|---|
Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Absorption; Administration, Intranasal; alpha-Cyclodextrins; Animals; beta-Cyclodextrins; Biological Availability; Buserelin; Cyclodextrins; Drug Stability; gamma-Cyclodextrins; Gonadotropin-Releasing Hormone; Magnetic Resonance Spectroscopy; Male; Nasal Mucosa; Oleic Acids; Oxidation-Reduction; Rats; Rats, Wistar | 1995 |